Horse /

Breed profile · FDA CVM July 2026 extract

Arab adverse-event record

Adverse-event filings for Arab (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.

Verify with FDA CVM →
#146 of 510
by report volume (all breeds)
467
FDA CVM reports on file
9.6%
death-coded share of reports
#54 of 275
by death-coded share (≥50 reports)

How the 467 reports break down

By recorded gender -- every report on file for Arab, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 31 23.25 15.5 7.75 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Arab drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Arab ranks #146 of 510 by total reports (467) and #54 of 275 by death-coded share (9.6%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#146
This breed, reports of 510
#54
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Arab has 467 reports now versus 461 in that prior snapshot: 6 more (1.3%).

Report change
+6
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Arab changes

Total Reports

467

Above-median volume

Deaths Reported

45

of 467 reports

Death-coded share of reports

9.6%

High death-coded share

Avg Age at Report

16.9 yr

424.0 kg avg weight

Breed Safety Scorecard

F (27/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
9.6%

Share of reports coded as a fatality

Euthanasia rate F
6.2%

Share of reports resulting in euthanasia

Full recovery rate A-
36.2%

Share of reports coded "Recovered/Normal"

5-year trend F
+94%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Arab death-coded reports 9.6%
Cross-breed median

9.6% of 467 arab reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Arab's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

10% 80th percentile Higher share than 80% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Arab 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 424.0 kg (934.9 lbs)

Top Reported Reactions

Lack of efficacy - NOS 47
Colic 45
Anorexia 35
INEFFECTIVE, GASTRIC ULCER(S) 30
Application site swelling 28
Death by euthanasia 28
Lethargy (see also Central nervous system depression in 'Neurological') 27
Diarrhoea 21

Most Referenced Drugs

Pergolide Mesylate 114
Omeprazole 52
Ivermectin(1.55%)/Praziquantel(7.75%) Paste 37
Ceftiofur Crystalline Free Acid 27
Detomidine Hydrochloride 24
Ivermectin, Praziquantel 23
Ivermectin + Praziquantel 20
Firocoxib 14

Outcome Breakdown

Recovered/Normal
169 (40.8%)
Outcome Unknown
147 (35.5%)
Ongoing
50 (12.1%)
Euthanized
29 (7.0%)
Died
17 (4.1%)
Recovered with Sequela
2 (0.5%)

Gender Distribution

Male 252 (54.0%)
Female 190 (40.7%)
Mixed 16 (3.4%)
Unknown 9 (1.9%)

Reports by Year

Year Reports Trend
2010 26
2011 35
2012 33
2013 30
2014 29
2015 52
2016 29
2017 26
2018 28
2019 31
2020 31
2021 16
2022 17
2023 21
2024 28
2025 31
2026 4

Arab: high death-coded share in the FDA CVM extract

Signature read: Arab's 9.6% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Arab sits at #146 of 510 by report volume among all breeds and #5 of 55 among horse breeds, with 467 reports and 45 (9.6%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #54 of 275. Mean age at report: 16.9 years, average weight 424.0 kg (934.9 lbs).

Top reported signs: Lack of efficacy - NOS (47), Colic (45), Anorexia (35). Most-referenced drug: Pergolide Mesylate (114 reports), followed by Omeprazole (52) and Ivermectin(1.55%)/Praziquantel(7.75%) Paste (37).

Outcome coding on 414 status-recorded reports is dominated by Recovered/Normal (40.8%). Annual submissions ranged 4-2,026 across 17 years on file.

Horse Breeds With a Similar Report Volume

Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.

Warmblood (unspecified)
541 reports · 7.0% death-coded
Paint
386 reports · 13.7% death-coded
Horse (other)
296 reports · 9.8% death-coded
Crossbred Equine/horse
190 reports · 7.9% death-coded
Tennessee Walking Horse
186 reports · 12.9% death-coded
Warmblood - Dutch
184 reports · 2.7% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Arab drawn from openFDA outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (9.6% death-coded here).

Cat (other) 9.7% · Cat Persian 9.7% · Cat Abyssinian cat 9.5% · Cat Mastiff (unspecified) 9.8% · Dog

What to do with this horse

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Arab? ▼
There are 467 adverse event reports involving Arab in the FDA database, of which 45 were death-coded (9.6% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Arab ranks #146 of 510 by report volume among all breeds PlainBreed indexes (#5 of 55 among horse breeds).
Where does Arab sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Arab is #146 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #5 of 55. Among breeds with at least 50 reports, its death-coded share ranks #54 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Arab? ▼
The most commonly reported adverse reactions for Arab are Lack of efficacy - NOS (47 reports), Colic (45 reports), Anorexia (35 reports), INEFFECTIVE, GASTRIC ULCER(S) (30 reports), Application site swelling (28 reports).
What drugs are most frequently associated with Arab adverse events? ▼
The drugs most frequently referenced in Arab adverse event reports are Pergolide Mesylate (114 reports), Omeprazole (52 reports), Ivermectin(1.55%)/Praziquantel(7.75%) Paste (37 reports), Ceftiofur Crystalline Free Acid (27 reports), Detomidine Hydrochloride (24 reports).
What is the average age of Arab in adverse event reports? ▼
The average age of Arab at the time of adverse event reports is 16.9 years, with an average weight of 424.0 kg (934.9 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Arab (Horse), extract as of July 2026 extract. 467 reports · 45 death-coded (9.6% of reports, not a mortality rate) · #146 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →